Atlas FDA

COLOGUARD

FDA premarket approval P130017/S004 · decided 2015-09-25

Approval details

PMA number
P130017
Supplement
S004
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol - OSB
Trade name
COLOGUARD
Generic name
System, colorectal neoplasia, DNA methylation and hemoglobin detection
Applicant
Exact Sciences Corporation
Date received
2015-07-27
Decision date
2015-09-25
Days to decision
60 days
Decision code
APPR
Product code
PHP
Advisory committee
Pathology
Expedited review
No
Location
Medison, WI
Statement
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.